Dyspnea in Patients With Pulmonary Fibrosis
NCT00611182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2013-11-18
Summary
This study has two aims:
1. To determine the relationship of shortness of breath (dyspnea) to other conditions present in patients with pulmonary fibrosis.
2. To define the relationship between shortness of breath and rate of functional decline in patients with pulmonary fibrosis.
Conditions
Sponsors & Collaborators
-
University of Chicago
collaborator OTHER -
American College of Chest Physicians
collaborator OTHER -
The John A. Hartford Foundation
collaborator OTHER -
Association of Specialty Physicians, Inc.
collaborator INDUSTRY -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Harold R. Collard, MD · University of California, San Francisco
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
NCT01718990 ·Status: COMPLETED
-
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511 ·Status: WITHDRAWN
-
Is COPD a Risk Factor for Cardiovascular Disease?
NCT02162095 ·Status: COMPLETED
-
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
NCT02055222 ·Status: COMPLETED
-
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
NCT05895409 ·Status: RECRUITING
-
Lung Function Decline and Disease Risk From Young Adulthood to Middle Age
NCT02245178 ·Status: COMPLETED
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
Evaluation of the Causes and Disease Processes of Chronic Lung Disease
NCT00001183 ·Status: COMPLETED
-
Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
NCT00540475 ·Status: COMPLETED
-
Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease
NCT07141810 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients
NCT05503030 ·Status: ACTIVE_NOT_RECRUITING
-
Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis
NCT06668051 ·Status: NOT_YET_RECRUITING
-
Breath Analysis in Lung Fibrosis
NCT02437448 ·Status: COMPLETED
-
Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)
NCT01419158 ·Status: COMPLETED
-
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
NCT00470327 ·Status: RECRUITING
-
Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
NCT06518473 ·Status: RECRUITING
-
Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases
NCT01600378 ·Status: RECRUITING
-
Idiopathic Pulmonary Fibrosis Job Exposures Study
NCT03211507 ·Status: COMPLETED
-
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF
NCT01874223 ·Status: COMPLETED
-
Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens
NCT02128711 ·Status: COMPLETED
-
Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
NCT00001462 ·Status: COMPLETED
-
Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study
NCT05719038 ·Status: UNKNOWN
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT06877091 ·Status: COMPLETED
-
Reliability and Validity of iOS in IPF
NCT04572971 ·Status: COMPLETED